COVID-19 trials registries data warehouse

 Return to trial list

Trial - NCT04950803


Column Value
Trial registration number NCT04950803
Full text link
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

First author
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov

None

Contact
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov

None

Registration date
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

2021-07-06

Recruitment status
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov

Not recruiting

Study design
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

RCT

Allocation
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Randomized

Design
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Parallel

Masking
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Blind label

Center
Last imported at : March 15, 2023, 4 a.m.
Source : ClinicalTrials.gov

single-center

Study aim
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Long covid

Inclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

inclusion criteria: individuals aged 18 and above; subjects who are mentally capable to participate in the study and provide informed consent; subjects who can communicate in chinese or english; subjects who are ambulatory and do not have difficulties travelling to the clinics for follow-up; subjects who do not have plans to leave hong kong in the subsequent two years after recruitment; and subjects who agree to give informed consent voluntarily.

Exclusion criteria
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

subjects who are unable to receive oral fluids; subjects who have received surgery involving the intestine within past 30 days; subjects who are pregnant or breastfeeding; and subjects who are immunocompromised, e.g. on cancer treatment, bone marrow/organ transplant, immune deficiency, poorly controlled hiv/aids.

Number of arms
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

2

Funding
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Chinese University of Hong Kong

Inclusion age min
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

18

Inclusion age max
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

100

Countries
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Hong Kong

Type of patients
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

Patients recovered from covid

Severity scale
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

N/A

Total sample size
Last imported at : July 23, 2023, midnight
Source : ClinicalTrials.gov

448

primary outcome
Last imported at : Feb. 13, 2023, 8:44 a.m.
Source : ClinicalTrials.gov

Alleviation of symptoms or complications

Notes
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

None

Phase
Last imported at : Nov. 16, 2021, 6:30 p.m.
Source : ClinicalTrials.gov

Not reported

Arms
Last imported at : July 8, 2021, 4 a.m.
Source : ClinicalTrials.gov

[{"arm_notes": "", "treatment_id": 1022, "treatment_name": "Probiotics", "treatment_type": "Microbiota intervention", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]